We provide you with 20 years of free, institutional-grade data for ALZN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALZN. Explore the full financial landscape of ALZN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Alzamend Neuro Inc(NASDAQ:ALZN) 
Alzamend Neuro is preclinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. With our two current and future product candidates, we aim to bring treatments or cures to market at a reasonable cost as quic...
The information provided in this report about ALZN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.